You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Head and Neck Squamous Cell Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +10 more
  • Regular care with additional administration of a semi-structured interview
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Sep 13, 2023

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (biological, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Panitumumab
  • +9 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jun 4, 2023

Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Locally Advanced Operable
  • Guangzhou, Guangdong, China
  • +1 more
Sep 4, 2023

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial (Tislelizumab, BGB-A425, LBL-007)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Head and Neck Cancer
  • (no location specified)
Jun 9, 2023

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Head

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • +4 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Following Salvage Surgery for RESidual or reCurrent sqUamous

Not yet recruiting
  • Head and Neck Cancer
  • Molecular Analyses
  • (no location specified)
Mar 28, 2023

Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

Not yet recruiting
  • Sinonasal Cancer
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 5, 2023

Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

Not yet recruiting
  • Recurrent Head and Neck Cancer
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 30, 2023

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial (ALE.C04, Pembrolizumab)

Not yet recruiting
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Sep 19, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Toronto (fMRI, Oral Pimonidazole)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • fMRI
  • Oral Pimonidazole
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Center
Oct 9, 2023

Prognostic Immune Biomarkers in HNSCC

Completed
  • Head and Neck Cancer
  • Squamous Cell Carcinoma
  • Tumour immunoprofile evaluation
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Jul 3, 2023

HLA-DR in Cell Cultures Isolated From Primary Squamous Cell

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Cancer
  • cell culture
  • Roma, Lazio, Italy
    Fondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023

Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,

Not yet recruiting
  • Head and Neck Cancer
  • +2 more
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Oct 25, 2023

Metastatic Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Portland (GB1211, Pembrolizumab, Placebo)

Not yet recruiting
  • Metastatic Melanoma
  • Head and Neck Squamous Cell Carcinoma
  • Portland, Oregon
    Providence Portland Medical Center
Jun 19, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Tianjin (Toripalimab, Stereotactic Body Radiation Therapy

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Tianjin, China
  • +1 more
May 16, 2023

Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Chengdu (Netopitam Palonosetron capsules and dexamethasone)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Netopitam Palonosetron capsules and dexamethasone
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital and Research Institute
Oct 22, 2023

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

Recruiting
  • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +4 more
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)

Not yet recruiting
  • Head Neck
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Center
Sep 14, 2023

Oligometastatic Squamous Cell Carcinoma of the Head and Neck Trial (Pembrolizumab, stereotattic ablation radiotherapy (SABR))

Not yet recruiting
  • Oligometastatic Squamous Cell Carcinoma of the Head and Neck
  • (no location specified)
Apr 14, 2023

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Panitumumab
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 16, 2023

Squamous Cell Carcinoma, Head Neck Cancer Trial in Tampa (Intensity-modulated radiotherapy, Magnetic Resonance Guidance)

Recruiting
  • Squamous Cell Carcinoma
  • Head and Neck Cancer
  • Intensity-modulated radiotherapy
  • Magnetic Resonance Guidance
  • Tampa, Florida
    Moffitt Cancer Center
Nov 13, 2023

Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (drug, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jul 13, 2023

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma Trial in Boston

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 11, 2023

Cancer of Head and Neck, Head Neck Cancer, Tumors, Head and Neck Trial in Boston, Saint Louis, New York (biological, procedure,

Active, not recruiting
  • Cancer of Head and Neck
  • +5 more
  • MK-3475 (neoadjuvant)
  • +6 more
  • Boston, Massachusetts
  • +2 more
Dec 9, 2022